DK0888340T3 - 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin - Google Patents
4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelinInfo
- Publication number
- DK0888340T3 DK0888340T3 DK97905897T DK97905897T DK0888340T3 DK 0888340 T3 DK0888340 T3 DK 0888340T3 DK 97905897 T DK97905897 T DK 97905897T DK 97905897 T DK97905897 T DK 97905897T DK 0888340 T3 DK0888340 T3 DK 0888340T3
- Authority
- DK
- Denmark
- Prior art keywords
- enodthelin
- dioxolyl
- pyrrolidine
- benzo
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60072496A | 1996-02-13 | 1996-02-13 | |
US79450597A | 1997-02-04 | 1997-02-04 | |
PCT/US1997/002128 WO1997030046A1 (en) | 1996-02-13 | 1997-02-10 | 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0888340T3 true DK0888340T3 (da) | 2002-11-04 |
Family
ID=27083691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97905897T DK0888340T3 (da) | 1996-02-13 | 1997-02-10 | 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0888340B1 (da) |
JP (1) | JP2000504727A (da) |
CN (1) | CN1079397C (da) |
AR (1) | AR005801A1 (da) |
AT (1) | ATE220673T1 (da) |
AU (1) | AU714597B2 (da) |
BR (1) | BR9707394A (da) |
CA (1) | CA2245684A1 (da) |
CZ (1) | CZ253698A3 (da) |
DE (1) | DE69714024T2 (da) |
DK (1) | DK0888340T3 (da) |
ES (1) | ES2182029T3 (da) |
HU (1) | HUP9902316A3 (da) |
IL (1) | IL125453A0 (da) |
NZ (2) | NZ503383A (da) |
PT (1) | PT888340E (da) |
WO (1) | WO1997030046A1 (da) |
ZA (1) | ZA971184B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6162927A (en) | 1994-08-19 | 2000-12-19 | Abbott Laboratories | Endothelin antagonists |
US7208517B1 (en) | 1994-08-19 | 2007-04-24 | Abbott Labortories | Endothelin antagonists |
US6124341A (en) * | 1996-02-13 | 2000-09-26 | Abbott Laboratories | Endothelin antagonists |
WO1998057933A1 (en) * | 1997-06-17 | 1998-12-23 | Abbott Laboratories | Pyrrolidine carboxylic acid derivatives as endothelin antagonists |
TR200101233T2 (tr) * | 1997-08-04 | 2002-06-21 | Abbott Laboratories | Endotelin antagonistleri. |
BR0112655A (pt) | 2000-07-19 | 2003-06-24 | Hoffmann La Roche | Derivados de pirrolidino como inibidores de metaloproteases |
WO2002017912A1 (en) * | 2000-08-31 | 2002-03-07 | Abbott Laboratories | Endothelin antagonists |
RU2259825C9 (ru) * | 2001-06-18 | 2006-04-10 | БиоДием Лимитед | Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2125980C1 (ru) * | 1991-11-05 | 1999-02-10 | Смитклайн Бичам Корпорейшн | Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов |
WO1994002474A1 (en) * | 1992-07-17 | 1994-02-03 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
ATE219077T1 (de) * | 1994-08-19 | 2002-06-15 | Abbott Lab | Endothelin antagoniste |
-
1997
- 1997-02-10 HU HU9902316A patent/HUP9902316A3/hu unknown
- 1997-02-10 DE DE69714024T patent/DE69714024T2/de not_active Expired - Lifetime
- 1997-02-10 AT AT97905897T patent/ATE220673T1/de not_active IP Right Cessation
- 1997-02-10 CN CN97193633A patent/CN1079397C/zh not_active Expired - Fee Related
- 1997-02-10 JP JP9529436A patent/JP2000504727A/ja active Pending
- 1997-02-10 EP EP97905897A patent/EP0888340B1/en not_active Expired - Lifetime
- 1997-02-10 CZ CZ982536A patent/CZ253698A3/cs unknown
- 1997-02-10 AU AU22678/97A patent/AU714597B2/en not_active Ceased
- 1997-02-10 BR BR9707394A patent/BR9707394A/pt not_active Application Discontinuation
- 1997-02-10 NZ NZ503383A patent/NZ503383A/en unknown
- 1997-02-10 NZ NZ331124A patent/NZ331124A/xx unknown
- 1997-02-10 CA CA002245684A patent/CA2245684A1/en not_active Abandoned
- 1997-02-10 ES ES97905897T patent/ES2182029T3/es not_active Expired - Lifetime
- 1997-02-10 PT PT97905897T patent/PT888340E/pt unknown
- 1997-02-10 WO PCT/US1997/002128 patent/WO1997030046A1/en not_active Application Discontinuation
- 1997-02-10 DK DK97905897T patent/DK0888340T3/da active
- 1997-02-10 IL IL12545397A patent/IL125453A0/xx unknown
- 1997-02-12 ZA ZA9701184A patent/ZA971184B/xx unknown
- 1997-02-12 AR ARP970100554A patent/AR005801A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ZA971184B (en) | 1997-08-27 |
IL125453A0 (en) | 1999-03-12 |
CN1215401A (zh) | 1999-04-28 |
NZ503383A (en) | 2002-02-01 |
HUP9902316A2 (hu) | 1999-11-29 |
CZ253698A3 (cs) | 1999-03-17 |
BR9707394A (pt) | 1999-04-06 |
JP2000504727A (ja) | 2000-04-18 |
ATE220673T1 (de) | 2002-08-15 |
DE69714024D1 (de) | 2002-08-22 |
AU714597B2 (en) | 2000-01-06 |
DE69714024T2 (de) | 2003-03-20 |
AU2267897A (en) | 1997-09-02 |
HUP9902316A3 (en) | 2001-12-28 |
PT888340E (pt) | 2002-12-31 |
AR005801A1 (es) | 1999-07-14 |
EP0888340B1 (en) | 2002-07-17 |
WO1997030046A1 (en) | 1997-08-21 |
CA2245684A1 (en) | 1997-08-21 |
NZ331124A (en) | 2000-05-26 |
CN1079397C (zh) | 2002-02-20 |
ES2182029T3 (es) | 2003-03-01 |
EP0888340A1 (en) | 1999-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
DK0912559T3 (da) | Kondenserede heterocykliske forbindelser som proteintyrosinkinaseinhibitorer | |
NO992725D0 (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
NO982907D0 (no) | Tyrosinderivater som <alfa>-v-integrininhibitorer | |
DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
NO20031540L (no) | Benzamidforbindelser som Apo-B-sekresjonsinhibitorer | |
NO20011575L (no) | Substituerte 3-cyanokinoliner som proteintyrosin-kinase- inhibitorer | |
FI962800A0 (fi) | Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina | |
DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
EE9900053A (et) | 4-(5-metüül-3-fenüülisoksasool-4-üül)benseensulfoonamiidi kristalliline vorm | |
ID17275A (id) | N-[4-(heteroarilmetil)fenil]-heteroarilamina | |
NO983603D0 (no) | Substituerte sulfonsyre N-£(aminoiminometyl)-fenylalkyl|-azaheterocyklamid-forbindelser | |
NO971137D0 (no) | Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser | |
DK0858452T3 (da) | Thiazolderivater som proteinkinase C-inhibitorer | |
DK0885215T3 (da) | Nye benzo-1,3-dioxolyl- og benzofuranyl-substituerede pyrrolidinderivater som endthelinantagonister | |
DK0891362T3 (da) | Pyrrolopyrrolon derivater som inhibitorer for neutrofil elastase | |
NO20010331D0 (no) | Ftalazinderivater som fosfodiesterase 4-inhibitorer | |
DK0799223T3 (da) | Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler | |
NO991994D0 (no) | Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriks-metalloproteaseinhibitorer | |
DK0888340T3 (da) | 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin | |
DE59712294D1 (de) | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionsäure-ethylesters | |
NO961333D0 (no) | Nye pyrazolderivater som angiotensin-II-antagonister | |
NO996244D0 (no) | Pyrrolidinkarboksylsyrederivater som endotelinantagonister | |
NO983829L (no) | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer | |
DE59914948D1 (de) | Verwendung von 1-(aminoalkyl)-3-chinoxalin-2-on-derivaten zur herstellung von als antioxidantien wirkenden zusammensetzungen |